Medical News

RSS

LinkMed third quarter net sales decrease to SEK 19.1 million

LinkMed decided to change the strategic focus of its operations, putting further focus on the transplantation sector, while intensifying and accelerating efforts to harvest the value of its associated companies. The change in strategy resulted in restructuring costs of SEK 6.3 million, charged to earnings in the third quarter. The restructuring carried out so far will result in an annual decrease in costs of SEK 7 million.

9 Nov 2010

Research reveals body’s defence mechanism against snail fever

Scientists have made a significant discovery about how the body defends itself against snail fever, a parasitic worm infection common in developing countries.

9 Nov 2010

Multidetector CT helps pinpoint causes of ischemic stroke

Multidetector computed tomography (CT) helps pinpoint the causes of ischemic strokes, the most common type of stroke, potentially speeding the delivery of life-saving treatments, according to a study published online and in the January issue of Radiology.

9 Nov 2010

Gefitinib exhibits potential as chemoprevention agent for pancreatic cancer

Gefitinib may be a promising chemoprevention agent for pancreatic cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

9 Nov 2010

Researchers examine impact of gene mutation on Salmonella bacterium growth rate

Most mutations in the genes of the Salmonella bacterium have a surprisingly small negative impact on bacterial fitness. And this is the case regardless whether they lead to changes in the bacterial proteins or not.

9 Nov 2010

Intercell aggregate revenues decrease 28.4% to EUR 21.1m in 9 months ended September 30, 2010

Today, Intercell AG announced its financial results for the third quarter of 2010 and presented an update on the Company's key R&D programs as well as changes to the Management Board.

9 Nov 2010

ORAL Solo Phase 3 study shows tasocitinib reduces signs and symptoms of active RA

Pfizer Inc. today announced results of ORAL Solo (1045), a Phase 3 study that showed tasocitinib (CP-690,550), an investigational, novel, oral JAK inhibitor, administered as monotherapy met two primary endpoints, demonstrating a statistically significant reduction in signs and symptoms of moderately to severely active rheumatoid arthritis (RA) and improvement in physical function as measured by ACR20 response rates and mean change in HAQ-DI, respectively, versus placebo at three months.

9 Nov 2010

Study explains link between morbid obesity and metabolic syndrome

Scientists have found that the fat cells and tissues of morbidly obese people and animals can reach a limit in their ability to store fat appropriately. Beyond this limit several biological processes conspire to prevent further expansion of fat tissue and in the process may trigger other health problems.

9 Nov 2010

GBS meningitis in infants still very serious

Although now less frequent because of preventive antibiotics, meningitis caused by group B streptococcal (GBS) bacteria is still a serious illness causing a high rate of death and severe complications in infants, reports a study in the November issue of The Pediatric Infectious Disease Journal.

9 Nov 2010

Fearless behavior in children related to neurological and genetic predisposition

"The results of this study show that fearless behavior in children can be identified and is related to neurological and genetic predisposition. This type of behavior has less correlation - at least in infancy - with standards of educational processes or parenting practice," says Dr. Inbal Kivenson-Baron, who carried out the study.

9 Nov 2010

Abbott, CHAI enter agreement to provide HIV testing to infants

Abbott and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI. A key focus of this cooperation will be sub-Saharan Africa, which the World Health Organization estimates to account for 90 percent of global HIV infections in children.

9 Nov 2010

Combination treatment with methotrexate and prednisone achieves remission in newly-developed RA

People with newly-developed rheumatoid arthritis or undifferentiated arthritis may be able to achieve remission, with continued drug therapy, after four months of treatment with methotrexate and prednisone, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

9 Nov 2010

UC Irvine study: Small amount of brain bleeding is common among older individuals

Neurologist Dr. Mark Fisher and neuropathologist Dr. Ronald Kim found that cerebral microbleeds are highly prevalent in the aging brain - and not primarily products of stroke-related injury, hypertension or neurodegenerative diseases such as Alzheimer's, as had been thought.

9 Nov 2010

Childhood abuse increases risk of type 2 diabetes in women: Study

A new study of nearly 70,000 women found a clear association between abuse in childhood and adolescence and the risk of type 2 diabetes in adult women.

9 Nov 2010

Speaking two languages could delay onset of Alzheimer's disease

A Canadian science team has found more dramatic evidence that speaking two languages can help delay the onset of Alzheimer's symptoms by as much as five years.

9 Nov 2010

ORVACS launches ERAMUNE 01 Phase II study to decrease HIV viral reservoirs

ORVACS has launched a Phase II study designed to test the hypotheses that combination therapy with potent antiviral agents and immunomodulator can lead to a decrease in the HIV viral reservoirs and, ultimately, to eradication of the virus. The study is currently being conducted at clinical sites in France, Spain, Italy, and the United Kingdom.

9 Nov 2010

Strong smoke-free policies reduce maternal smoking and improve fetal outcomes

New research released today takes a look at birth outcomes and maternal smoking, building urgency for more states and cities to join the nationwide smoke-free trend that has accelerated in recent years. According to the new data, strong smoke-free policies can improve fetal outcomes by significantly reducing the prevalence of maternal smoking.

9 Nov 2010

AHF joins breakthrough research for HIV control

A study published in Science yesterday, reveals what could be the key to why some HIV/AIDS patients' immune systems keep the disease at bay without medication.

9 Nov 2010

Africare announces $1.42M grant from ExxonMobil for battle against malaria in Africa

Africare President Darius Mans announced today new investments from ExxonMobil to extend their partnership in its fight against malaria. ExxonMobil, which has long been a supporter of Africare, will fund three key malaria prevention and intervention programs in Africa.

9 Nov 2010

Seattle Genetics, Millennium to feature SGN-35 in two oral presentations at ASH Annual Meeting

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited today announced that brentuximab vedotin (SGN-35) will be featured in two oral presentations at the 52nd American Society of Hematology (ASH) Annual Meeting and Exposition being held December 4-7, 2010 in Orlando, FL.

9 Nov 2010

Medical News

LinkMed third quarter net sales decrease to SEK 19.1 million

Research reveals body’s defence mechanism against snail fever

Multidetector CT helps pinpoint causes of ischemic stroke

Gefitinib exhibits potential as chemoprevention agent for pancreatic cancer

Researchers examine impact of gene mutation on Salmonella bacterium growth rate

Intercell aggregate revenues decrease 28.4% to EUR 21.1m in 9 months ended September 30, 2010

ORAL Solo Phase 3 study shows tasocitinib reduces signs and symptoms of active RA

Study explains link between morbid obesity and metabolic syndrome

GBS meningitis in infants still very serious

Fearless behavior in children related to neurological and genetic predisposition

Abbott, CHAI enter agreement to provide HIV testing to infants

Combination treatment with methotrexate and prednisone achieves remission in newly-developed RA

UC Irvine study: Small amount of brain bleeding is common among older individuals

Childhood abuse increases risk of type 2 diabetes in women: Study

Speaking two languages could delay onset of Alzheimer's disease

ORVACS launches ERAMUNE 01 Phase II study to decrease HIV viral reservoirs

Strong smoke-free policies reduce maternal smoking and improve fetal outcomes

AHF joins breakthrough research for HIV control

Africare announces $1.42M grant from ExxonMobil for battle against malaria in Africa

Seattle Genetics, Millennium to feature SGN-35 in two oral presentations at ASH Annual Meeting

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News